You just read:

Mallinckrodt Lupus Phase 4 Clinical Study for Acthar® Gel (Repository Corticotropin Injection) Completes Enrollment in Difficult-to-Manage Population

News provided by

Mallinckrodt plc

Apr 23, 2019, 06:45 ET